Sushil Patel
Chief Executive Officer bei REPLIMUNE GROUP, INC.
Vermögen: 2 Mio $ am 31.03.2024
Profil
Sushil Patel is currently the Chief Executive Officer & Director at Replimune Group, Inc. since 2024 and an Independent Director at Revolution Medicines, Inc. since 2022.
Previously, he worked at Genentech, Inc. from 2002 to 2021, where he held the position of Vice President-Franchise & Head-Oncology from 2008 to 2021.
Dr. Patel completed his graduate degree at Imperial College London in 1993, obtained a doctorate degree from the University of London in 1999, and received his undergraduate degree from the University of Warwick in 1992.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
REPLIMUNE GROUP, INC.
0,38% | 01.04.2024 | 232 208 ( 0,38% ) | 2 Mio $ | 31.03.2024 |
| 10.04.2024 | 15 700 ( 0,01% ) | 506 011 $ | 31.03.2024 |
Aktive Positionen von Sushil Patel
| Unternehmen | Position | Beginn |
|---|---|---|
| REPLIMUNE GROUP, INC. | Chief Executive Officer | 01.04.2024 |
| REVOLUTION MEDICINES, INC. | Director/Board Member | 16.06.2022 |
Ehemalige bekannte Positionen von Sushil Patel
| Unternehmen | Position | Ende |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01.05.2021 |
Ausbildung von Sushil Patel
| Imperial College London | Graduate Degree |
| University of London | Doctorate Degree |
| University of Warwick | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| REVOLUTION MEDICINES, INC. | Health Technology |
| REPLIMUNE GROUP, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
